Moreover, FBLN3 overexpression notably decreased the activities of MMP-2 and MMP-9 and repressed the invasion of NSCLC A549 cells; thus, it could be used as a therapeutic strategy for NSCLC (36). The gene discussed is EFEMP1; the disease is non-small cell lung carcinoma.